Early test of experimental heart drug begins
NCT ID NCT07218627
Summary
This early-stage study is testing whether a new drug called NNC0537-1482 is safe for people with heart failure. Researchers will give the drug or a placebo to 36 participants to see how their bodies handle it and check for side effects. The main goal is to understand the drug's safety profile before testing whether it actually helps treat heart failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Richmond Pharmacology
RECRUITINGLondon, SE1 1YR, United Kingdom
Conditions
Explore the condition pages connected to this study.